Back to today’s briefing

Story perspectives

Revolutionary Bone Marrow Transplant Offers Hope for Sickle Cell

3/3/2025

47 6

Summary

Story summary

A groundbreaking bone marrow transplant technique for sickle cell disease, crafted by experts from Vanderbilt University, Johns Hopkins, and UCSF, is yielding remarkable outcomes. In a study involving 38 adults, an astounding 97% no longer required immunosuppressive therapy after one year, and the two-year survival rate soared to 95%. This innovative approach is not only less toxic but also more cost-effective than traditional gene therapy.

1 of 1

Story summary

A groundbreaking bone marrow transplant technique for sickle cell disease, crafted by experts from Vanderbilt University, Johns Hopkins, and UCSF, is yielding remarkable outcomes. In a study involving 38 adults, an astounding 97% no longer required immunosuppressive therapy after one year, and the two-year survival rate soared to 95%. This innovative approach is not only less toxic but also more cost-effective than traditional gene therapy.